Nathan D. Jorgensen insider trades
Open-market stock purchases and sales by Nathan D. Jorgensen, Chief Financial Officer at Voyager Therapeutics, Inc, from SEC Form 4 filings since Feb 9, 2021.
Get free alerts when Nathan D. Jorgensen files a new trade →